Effects of tamoxifen on cervicovaginal smears from patients with breast cancer

Acta Cytologica

Volumn 44, Issue 2, 2000, Pages 141-146

  Abadi, Maria A ^a,b   Barakat, Richard R ^a   Saigo, Patricia E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b JACOBI MEDICAL CENTER   (United States)

Author keywords

Breast neoplasms; Cervical smears; Tamoxifen; Vaginal smears

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CELL; ESTROGEN ACTIVITY; FEMALE; HISTIOCYTE; HUMAN; HUMAN CELL; MATURATION; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY;

EID: 0034073702     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000326351     Document Type: Article

References (17)

1. Adjuvant tamoxifen in the management of operable breast cancer: The Scottish Trial: Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh. Lancet 1987;2:171-175
2. Anzai Y, Holinka CF, Kuramoto H, Gurpide E: Stimulatory effects of 4-hydroxytamoxifen on proliferation of human endometrial adenocarcinoma cells (Ishikawa line). Cancer Res 1989;49:2362-2365
3. Barakat RR: The effect of tamoxifen on the endometrium. Oncology (Huntingt) 1995;9:129-134
4. Barakat RR: Tamoxifen and endometrial neoplasia. Clin Obstet Gynecol 1996;39:629-640
5. Barakat RR, Wong G, Curtin JP, Vlamis V, Hoskins WJ: Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features [see comments]. Gynecol Oncol 1994;55:164-168
6. Boccardo F, Bruzzi P, Rubagotti A, Nicolo GU, Rosso R: Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients. Oncology 1981;38:281-285
7. De Muylder X, Neven P, De Somer M, Van Belle Y, Vanderick G, De Muylder E: Endometrial lesions in patients undergoing tamoxifen therapy. Int J Gynaecol Obstet 1991;36: 127-130
8. Ferrazzi E, Cartei G, Mattarazzo R, Fiorentino M: Oestrogen-like effect of tamoxifen on vaginal epithelium (lett). Br Med J 1977;1:1351-1352
9. Grenman SE, Roberts JA, England BG, Gronroos M, Carey TE: In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetate. Gynecol Oncol 1988;30:239-250
10. Gu M, Jacobsen J, Erroll M, Hoda SA: Pap smears of patients on tamoxifen (lett). Diagn Cytopathol 1997;16:96-97
11. Kurman RJ, Solomon D: The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. New York, Springer-Verlag, 1994
12. Lahti E, Vuopala S, Kauppila A, Blanco G, Ruokonen A, Laatikainen T: Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen. Gynecol Oncol 1994;55:410-414
13. Magriples U, Naftolin F, Schwartz PE, Carcangiu ML: High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 1993;11:485-190
14. McGonigle KF, Lantry SA, Odom-Maryon TL, Chai A, Vasilev SA, Simpson JF: Histopathologic effects of tamoxifen on the uterine epithelium of breast cancer patients: Analysis by menopausal status. Cancer Lett 1996;101:59-66
15. Meisels A: The menopause: A cytohormonal study. Acta Cytol 1966;10:49-55
16. Silva EG, Tornos CS, Follen-Mitchell M: Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: The effects of tamoxifen. Int J Gynecol Pathol 1994;13:248-258
17. Stern CE, Tom PM, Rios CN: Cervicovaginal cytology in women treated with tamoxifen for breast carcinoma (abstr). Am J Clin Pathol 1998;109:485